ProAir®HFA (albuterol sulfate) Inhalation Aerosol is indicated in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
Safety Information/Healthcare Professionals
- Inhaled albuterol sulfate can produce paradoxical bronchospasm
that may be life-threatening. It should be recognized that paradoxical
bronchospasm, when associated with inhaled formulations, frequently
occurs with the first use of a new canister.
- Fatalities have been reported in association with excessive
use of inhaled sympathomimetic drugs in patients with asthma.
- ProAir® HFA, as with all sympathomimetic amines, should be
used with caution in patients with cardiovascular disorders (especially
coronary insufficiency, cardiac arrhythmias, and hypertension),
convulsive disorders, hyperthyroidism, and diabetes.
- Potential drug interactions can occur with beta-blockers,
diuretics, digoxin, or monoamine oxidase inhibitors, and tricyclic
antidepressants.
- Do not exceed the recommended dose.
- Adverse events, which occurred at an incidence rate
of at least 3% with ProAir® HFA, include headache, tachycardia,
pain, dizziness, pharyngitis, and rhinitis.
ProAir® HFA is a registered trademark of Teva Specialty Pharmaceuticals
LLC.